NCT00456937

Brief Summary

SSRI's has been demonstrated to be partially effective in schizophrenia and OCD. We therefore suggest that Escitalopram up to 20 mg /d in those patients could be effective in reducing obsessive compulsive symptomatology

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for phase_4 schizophrenia

Timeline
Completed

Started Jul 2006

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2006

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

December 3, 2006

Completed
4 months until next milestone

First Posted

Study publicly available on registry

April 5, 2007

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2008

Completed
Last Updated

January 27, 2009

Status Verified

January 1, 2009

Enrollment Period

2.2 years

First QC Date

December 3, 2006

Last Update Submit

January 26, 2009

Conditions

Schizophrenia

Interventions

EscitalopramDRUG

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who suffer from schizophrenia and OCD

You may not qualify if:

  • Substance abuse,
  • Serious medical condintions,
  • Being on SSRI treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beer Yaakov MHC

Beer Yaakov, 70350, Israel

Location

MeSH Terms

Conditions

Schizophrenia

Interventions

Escitalopram

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Intervention Hierarchy (Ancestors)

PropylaminesAminesOrganic ChemicalsNitrilesBenzofuransHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic Compounds

Study Officials

  • Rafael Octavio Stryjer, M.D.

    Beer Yaakov Mental Health Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
NON RANDOMIZED
Masking
NONE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV

Study Record Dates

First Submitted

December 3, 2006

First Posted

April 5, 2007

Study Start

July 1, 2006

Primary Completion

September 1, 2008

Study Completion

September 1, 2008

Last Updated

January 27, 2009

Record last verified: 2009-01

Locations

IL(1)